The importance of renal net acid excretion as a determinant of fasting urinary calcium excretion  by Lemann, Jacob et al.
Kidney International, Vol. 29 (1986), pp. 743—746
The importance of renal net acid excretion as a determinant of
fasting urinary calcium excretion
JACOB LEMANN, JR., RICHARD W. Gity, WILLIAM J. MAIERHOFER and HERMAN S. CHEUNG
Departments of Medicine and Biochemistry, and the Clinical Research Center, Medical College of Wisconsin, Milwaukee,
Wisconsin 53226, USA
The importance of renal net acid excretion as a determinant of fasting
urinary calcium excretion. To evaluate the effects of changing rates of
fixed acid production on fasting urine Calcreatinine, we studied five
healthy men fed constant diets during control conditions (serum HCO3
27.3 2.6 SD mEq/liter and blood H 40.4 1.5 SEq/liter) and then
during the administration of NH4C1 3.0 mEqlkg/day (serum HCO3 22.5
4.9 mEq/liter; P < 0.025, and H4 46.8 2.3 mEq/liter; P < 0.005).
In addition to the expected increase in daily urinary Ca excretion from
5.2 2.0 to 12.5 3.0 mmole/day; P < 0.001 as daily urinary net acid
excretion was increased from 48 32 to 257 33 mEq/day; P < 0.001
we observed that fasting urinary net acidlcreatinine excretion also
increased from 2.9 1.2 to 11.1 1.2 mEq/mmole creatinine; P <
0.001 and fasting urine Calcreatinine increased from 0.158 0.111 to
0.456 0.109 mmoie/mmole creatinine; P < 0.005. The additional Ca
appearing in the urine during acidosis ultimately reflected augmented
net bone resorption since daily urinary hydroxyproline excretion was
increased from 0.232 0.062 to 0.377 0.108 mmole/day; P < 0.01.
Since variations in diet composition can cause fixed acid production and
thus renal net acid excretion to vary from about zero to 200 mEq/day,
such a range could cause fasting Calcreatinine to vary from 0.09 to 0.37
mmole/mmole (0.03 to 0.13 mglmg) and should be taken into account in
the evaluation of fasting Calcreatinine.
The excretion of calcium into the urine after overnight fasting
has been widely employed to categorize patients with hypercal-
ciuria [1]. Elevated rates of fasting urinay calcium excretion
when serum calcium levels and glomerular filtration rates are
normal reflect reduced renal tubular calcium reabsorption and,
ultimately, increased net bone resorption [2]. We have previ-
ously observed that fasting urinary calcium excretion among
healthy adults is closely correlated to prevailing serum concen-
trations of 1 ,25-(OH)2-vitamin D and independent of dietary
calcium intake [3]. Other factors are known to increase daily
urinary calcium excretion, especially increases in acid produc-
tion and renal net acid excretion when dietary protein intake is
increased [4—8] or acidosis is produced by the administration of
NH4C1 [9—11]. However, the effects of variations in acid pro-
duction on the relationships between fasting urinary calcium
excretion and net acid excretion has apparently not been
emphasized. In the present studies we have evaluated the
effects of modest NH4C1 acidosis on fasting urinary composi-
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tion and have assessed the importance of fasting net acid
excretion as a determinant of fasting urinary calcium excretion.
In addition, we have examined the effects of induced acidosis
on urinary hydroxyproline excretion as an index of bone
resorption and on the increase in urinary calcium excretion
after oral calcium administration as an index of intestinal
calcium absorption.
Methods
We studied five healthy men ages 21 to 32 years weighing 74.7
4.2 SD kg with their consent in the Medical College of
Wisconsin Clinical Research Center under a protocol approved
by the Medical College of Wisconsin Human Research Review
Committee. Each subject was studied first during control acid
base conditions. Each ate a constant whole food diet that did
not contain gelatin and which provided (by estimation) for the
group an average of Ca 32.9 1.9 mmole/day, P04 61.0 4.0
mmole/day, Mg 13.7 1.5 mmole/day, Na 158 20 mmole/day
and K 98 13 mmole/day. On day one and day two 24 hr urines
were collected. On the morning of the third day, after a 12 hr
overnight fast, a fasting two hr urine was collected from 0600 to
0800 hr. The subjects ate breakfast which provided 7 mmoles
Ca immediately thereafter, and collected a subsequent four hr
urine from 0800 to 1200 hr. The remaining portion of the third 24
hr urine (1200 to 0600 hr) was also collected. On the morning of
day four, a two hr fasting urine was again collected between
0600 and 0800 hr. The subjects then ate breakfast together with
an additional oral 25 mmol Ca load as calcium glubionate
(Neo-Calglucon®) and collected a four hr urine between 0800
and 1200 hr. Blood samples were obtained before breakfast and
at 1000 hr on days three and four.
Following the completion of the control phase, each subject
was discharged to take NH4C1 in divided doses three times daily
with meals. The total daily dose was gradually increased to 3.0
mEq/kglday over four days and then held constant. After six
additional days at home on NH4C1 (10 days of NH4C1) the
subjects were readmitted, fed the same diet, continued on
NH4C1 and studied over four days using the same protocol as in
the control phase. The last previous dose of NH4C1 was given
with supper the evening before the fasting urine collections and
the next dose was given with breakfast alone or breakfast and
the Ca load.
The 24 hr, fasting, post-breakfast and post-breakfast + Ca
load urines were analyzed for Ca, P04, Mg, creatinine, pH,
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Table 1. Blood composition during control and during NH4CI acidosis
Control Acidosis P
Blood W, nEq/!ifer pH 40.4 1.5 46.8 2.3 +6.4 1.7 <0.005
7.39 7.33
Serum HCO3, mEqI!iter 27.3 2.6 22.5 4.9 —4.9 2.6 <0.025
Serum Ca, mmolelliter 2.35 0.07 2.32 0.07 —0.03 0.01 <0.005
Serum PU4, mmole/Iiter 1.21 0.16 1.22 0.11 +0,01 0.10 NS
Serum Mg, mmole/liter 0.88 0.03 0.82 0.03 —0.06 0.02 <0.005
Creatinine, .moleI1iter 115 6 108 7 —7 8 NS
l,25-(OH)2-D, prno!e/!iter 79 15 84 9 +5 10 NS
25-OH-D, mo!eI!iter 73 14 75 21 +2 12 NS
iPTH, 1.dEq/ml 6.0 1.8 5.2 2.0 —0.8 0.9 NS




Daily Ca, mmo!e/day 5.2 2.0 12.5 3.0 +7.3 1.8 <0.001
P04, mmolelday 34.6 8.1 42.9 11.2 +8.4 5.5 <0.05
Mg, mmo!elday 5.2 1.3 5.8 0.9 +0.6 1.3 NS
Creatinine, mmole/day 17.7 2.6 18.0 2.1 +0.3 0.9 NS
Net acid, mmolelday 48 32 257 33 +209 10 <0.01
Hydroxyproline, mmolelday 0.232 0,062 0.377 0.108 +0. 145 0.68 <0.01
cAMP, umo!eIday 4.75 0.82 4.42 0.98 —0.33 1.18 NS
Oxalate, mmo!elday 0.32 0.01 0.23 0.02 —0.09 0.10 NS
Fasting Ca/creatinine, mmo!elmmo!e 0.158 0.111 0.456 0.109 +0.299 0.082 <0.005
Mg/creatinine, mmole/mmo!e 0.245 0.067 0.271 0.089 +0.026 0.096 NS
TmPO4/GFR, mmole/liter 1.18 0.15 1.10 0.14 —0.08 0.10 NS
Net acid/creatinine, mEqlmmole 2.9 1.2 11.1 1.2 +8.2 1.2 <0.001
Uxalate/creatinine, mo1e/mmo1e 14.6 4.5 14.4 2.8 —0.2 4.9 NS
total CO2 content, NH4 and oxalate. In addition, hydroxypro-
line, cAMP and oxalate were measured in the 24 hr urines.
Whole blood pH and serum CO2 content, Ca, Mg, P04, creat-
mine and 25-OH-vitamin D were measured. The analytical
methods used have been described previously [3, 121. Im-
munoreactive PTH was measured as described previously [3,
121. Serum l,25-(OH)2-D was measured using the calf thymus
receptor for competitive binding assay after extraction of the
serum samples with acetonitrile and purification using sequen-
tial C18 and silica "Sep-Paks" [13]. Twenty-three serum spec-
imens with serum 1 ,25-(OH)2-D concentrations ranging from 35
to 190 M using HPLC purification and the chick duodenal
receptor [3] had an average serum 1 ,25-(OH)2-D concentration
of 98 50 M and, when also analyzed by the calf thymus
method, an average 1,25-(OH)2-D concentration of 103 34
PM; R = 0.75.
Results are presented as group means SD and changes from
control were analyzed utilizing the Student's paired t test [14].
Results
The results are summarized in Tables 1—3. The administration
of NH4C1 produced, as expected, mild metabolic acidosis
without detectible changes in serum l,25-(OH)2-D or PTH
concentrations (Table 1). Serum total Ca and Mg concentrations
fell slightly, but significantly. Metabolic acidosis was accompa-
nied by a marked rise in daily urinary net acid and Ca excretion
as expected, as well as a rise in fasting urinary excretion of net
acid and of Ca (Table 2). Urinary hydroxyproline excretion rose
in each subject (Table 2). Although daily urinary PU4 excretion
rose slightly (Table 2), neither serum P04 concentrations (Table
Fasting 0.158 0.118 0.456 0.109
Breakfast 0.347 0.207 0.729 0.202
+0.199 0.133 +0.27 0.173 +0.071 0.074 NS
P <0.05 <0.05
Fasting 0.167 0.109 0.454 0.059
Breakfast
+ 25 mmole
Ca load 0.398 0.217 0.760 0.241
+0,231 0.171 +0.306 0.219 +0.075 0.116 NS
P <0.05 <0.05
1) nor fasting TmPO,1IGFR changed (Table 2). Daily urinary
cAMP excretion also did not change (Table 2).
As shown in Table 3, fasting urinary Ca/creatinine increased
after both breakfast alone (7 mmole Ca) or breakfast plus the 25
mmole Ca load (32 mmole Ca) during both the control and
acidosis phases of the studies. However, the increments were
not significantly greater while the subjects were acidotic when
compared to control.
Discussion
Previous studies in healthy adults have shown that increasing
rates of fixed acid production, caused by increasing dietary
protein intake or administering NH4CI, augments renal net acid
excretion and daily urinary Ca excretion [4—111. During acidosis
serum total Ca tends to fall because of reduced Ca-binding by
serum proteins [15] while serum ionized or ultrafilterable Ca
concentrations do not change or rise [151. However, GFR tends
Table 3. Fasting urine Ca/creatinine and urine Ca/creatinine over four
hours following breakfast or breakfast + 25 mmole Ca load during
control and during NH4CI acidosis
Control Acidosis P
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to fall [16] so that the glomerular filtration of Ca actually
decreases. Thus, the calciuria accompanying acidosis is the
result of inhibition of net renal tubular Ca reabsorption [16], an
effect that appears to be mediated by reduced bicarbonate
availability in the distal nephron [17]. The present studies
provide indirect confirmation of this physiological sequence in
the context of the evaluation of fasting urine composition.
Balance studies have shown that net intestinal Ca absorption
does not increase significantly when acid production is in-
creased [4-7, 18]. The present studies provide additional indi-
rect evidence that intestinal Ca absorption is not altered by mild
metabolic acidosis since the increments in urinary Ca excretion
following either the 7 or 32 mmole oral Ca loads were not
augmented. The balance studies [4—11] have also shown that
increased rates of urinary Ca excretion that occur when acid
production rates are increased result in more negative Ca
balances, the Ca being lost from the skeleton. The present
observation that mild acidosis is accompanied by increased
urinary hydroxyproline excretion provides further support for
the view that augmented rates of acid production stimulate bone
resorption.
The mechanisms by which augmented fixed acid production
rates stimulate net bone resorption remain to be fully defined.
The present studies reconfirm our previous observations show-
ing that mild acidosis does not alter serum PTH or 1 ,25-(OH)2-D
concentrations [11]. Coe and associates [15] observed that
serum PTH levels rose during experimental acidosis and pro-
posed that the calciuria accompanying acidosis somehow pro-
voked PTH secretion, which in turn stimulated bone resorption.
However, serum ionized Ca concentrations in those studies did
not change during acidosis and the precise mechanism respon-
sible for the apparent rise in serum PTH remains uncertain.
Experimental acidosis provokes calciuria in patients with
hypoparathyroidism so that alterations in PTH are apparently
not required for the response either in bone or kidney [16].
Furthermore, in the present as well as previous studies [11],
acidosis did not alter urinary cAMP excretion suggesting that
the effect of prevailing PTH levels on the kidney were un-
changed [19]. Moreover, acidosis does not appear to alter the
skeletal response to PTH [20]. Thus, activation of the parathy-
roid-vitamin D endocrine system, which can stimulate bone
resorption, does not mediate the effect of acidosis. Bone
resorption must either be stimulated as a direct effect of
acidosis [21] or, speculatively, as a consequence of some as yet
undefined humoral mechanism.
The results of the present study clearly demonstrate that the
rate of renal net acid excretion is an important determinant of
fasting urinary Ca excretion and therefore must be taken into
consideration in the evaluation and interpretation of measure-
ments of fasting urinary Ca excretion, especially when those
measurements are utilized in an attempt to define the presence
of a renal Ca leak. In the sense that augmented rates of acid
production and net acid excretion are accompanied by inhibi-
tion of renal tubular Ca reabsorption [16], such increased rates
of net acid excretion do in fact result in a renal Ca leak when
serum Ca concentrations are normal. Moreover, such a leak
occurs in the absence of detectible compensatory alterations in
parathyroid function. Among healthy subjects, differences in
dietary composition cause net fixed acid production and thus
renal net acid excretion to vary over a range of approximately
zero to 200 mEq/day [22, 23]. In view of the observations during
control and NH4C1 (Table 2), such a range of net acid excretion
rates would predict that fasting urinary Ca/creatinine might
vary from 0.09 to 0.37 mmole/mmole (0.03 to 0.13 mg/mg).
Such an effect would presumably be independent of the effect
of serum 1 ,25-(OH)2-D concentrations to augment fasting uri-
nary Ca/creatinine by a direct effect on bone independent of
dietary Ca [3]. This latter effect quantitatively causes fasting
Ca/creatinine to range from 0.06 to 0.34 mmole/mmole (0.02 to
0.12 mg/mg) as serum 1 ,25-(OH)2-D levels vary over the normal
range of 40 to 140 p. Speculatively therefore, the effects of
increasing net fixed acid production and of increasing serum
1 ,25-(OH)2-D concentrations to augment fasting urine Ca/cre-
atinine are additive.
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